Since the approval of anti-vascular endothelial growth factor (anti-VEGF) pharmacotherapy in 2006, the prevalence of legal blindness and visual impairment caused by nAMD has been considerably reduced, removing nAMD from the list of incurable diseases.3 This evidence concerns the gene VEGFA and Blindness.